{"transactions":[{"id":1320973,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-27T21:30:04.000Z","date":"2024-12-24","kind":"exercise","planned":true,"acquired":false,"shares":29709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option became vested and exercisable on December 19, 2023 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":270291,"derivative":{"exercise_price":8.94,"expiration_date":"2032-12-30","underlying":"Common Stock","underlying_shares":29709},"source":{"system":"sec-edgar","filing":"0001562180-24-008599","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024008599/primarydocument.xml","form_type":"4"}},{"id":1320972,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-12-27T21:30:04.000Z","date":"2024-12-24","kind":"sale","planned":true,"acquired":false,"shares":1729,"price":30.0803,"value":52008.8387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.03 to $30.13, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6716,"source":{"system":"sec-edgar","filing":"0001562180-24-008599","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024008599/primarydocument.xml","form_type":"4"}},{"id":1320971,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-12-27T21:30:04.000Z","date":"2024-12-24","kind":"sale","planned":true,"acquired":false,"shares":27980,"price":29.6607,"value":829906.386,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.03 to $30.02, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8445,"source":{"system":"sec-edgar","filing":"0001562180-24-008599","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024008599/primarydocument.xml","form_type":"4"}},{"id":1320970,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-12-27T21:30:04.000Z","date":"2024-12-24","kind":"exercise","planned":true,"acquired":true,"shares":29709,"price":8.94,"value":265598.46,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,187 shares purchased on November 15, 2023, 2,254 shares purchased on May 15, 2024 and 2,275 shares purchased on November 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":36425,"source":{"system":"sec-edgar","filing":"0001562180-24-008599","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024008599/primarydocument.xml","form_type":"4"}},{"id":1433648,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-14T20:15:40.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024."}],"balance_after":23125,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":23125},"source":{"system":"sec-edgar","filing":"0001562180-24-006262","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006262/primarydocument.xml","form_type":"4"}},{"id":1433647,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T20:15:40.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":138750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":138750,"derivative":{"exercise_price":17.05,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":138750},"source":{"system":"sec-edgar","filing":"0001562180-24-006262","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006262/primarydocument.xml","form_type":"4"}},{"id":1801909,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-18T23:13:10.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":133333,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":133333},"source":{"system":"sec-edgar","filing":"0001562180-23-006453","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023006453/primarydocument.xml","form_type":"4"}},{"id":2072692,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-03T21:44:32.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option become vested and exercisable on December 19, 2023 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":300000,"derivative":{"exercise_price":8.94,"expiration_date":"2032-12-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001562180-23-000045","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023000045/primarydocument.xml","form_type":"4"}},{"id":2096172,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-12-05T21:21:12.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":34850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio, rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":34850},"source":{"system":"sec-edgar","filing":"0001062993-22-023381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000106299322023381/form4.xml","form_type":"4"}},{"id":2096171,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-12-05T21:21:12.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":169849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio, rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":169849},"source":{"system":"sec-edgar","filing":"0001062993-22-023381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000106299322023381/form4.xml","form_type":"4"}},{"id":2096170,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-12-05T21:21:12.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":88991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents Company Options (as defined in the Merger Agreement), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio, rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":88991},"source":{"system":"sec-edgar","filing":"0001062993-22-023381","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000106299322023381/form4.xml","form_type":"4"}},{"id":2096169,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-05T21:21:12.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":35226,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares underlying the Earnout RSU Awards were cancelled and converted into the right to receive the Per Share Merger Consideration (as defined in the Merger Agreement). 1,822 shares of Rocket common stock were withheld to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-22-023381","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000106299322023381/form4.xml","form_type":"4"}},{"id":2096168,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-05T21:21:12.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":35226,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of common stock underlying restricted stock units granted pursuant to that certain Agreement and Plan of Merger, dated as of March 22, 2021, by and among the Issuer, Renovacor Holdings, Inc. and CHAQ 2 Merger Sub, Inc. (the \"SPAC Merger Agreement\") as Earnout RSU Awards (as defined in the SPAC Merger Agreement). Pursuant to the terms of the SPAC Merger Agreement, the Earnout RSU Awards have fully vested upon the consummation of the merger."}],"balance_after":35226,"source":{"system":"sec-edgar","filing":"0001062993-22-023381","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000106299322023381/form4.xml","form_type":"4"}},{"id":2096167,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-05T21:21:12.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":17425,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying Company Time-Vesting RSUs (as defined in the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. (\"Rocket\") and the other parties thereto (the \"Merger Agreement\")). Each unvested RSU outstanding immediately prior to the First Effective Time (as defined in the Merger Agreement) was accelerated, cancelled and converted into the right to receive a number of Rocket common stock, rounded to the nearest whole number, equal to the number of shares of Issuer common stock underlying such Company Time-Vesting RSU multiplied by the Exchange Ratio (as defined in the Merger Agreement)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-22-023381","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000106299322023381/form4.xml","form_type":"4"}},{"id":2425224,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-01-26T18:30:32.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":34850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in equal monthly installments on the24th of each month for the remaining 36months, subject to the continuous service of the Reporting Person on such vesting date."}],"balance_after":34850,"derivative":{"exercise_price":6.45,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":34850},"source":{"system":"sec-edgar","filing":"0000899243-22-003302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924322003302/doc4.xml","form_type":"4"}},{"id":2425223,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-26T18:30:32.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":17425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on January 24, 2023, subject to continued service with the Company."}],"balance_after":52651,"source":{"system":"sec-edgar","filing":"0000899243-22-003302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924322003302/doc4.xml","form_type":"4"}},{"id":2461091,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-12-22T16:30:30.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":88991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 2, 2021, the Reporting Person was granted a stock option that will vest and become exercisable in full on December 2, 2021, subject to the achievement of certain performance based milestones set forth in the\nEmployment Agreement by and between the Issuer and the Reporting Person, dated May 5, 2021 (with the achievement of such performance based milestones subject to the approval of the Compensation Committee of the Board\nof Directors of the Issuer), and the continuous service of the Reporting Person on such vesting date. On December 20, 2021, the Compensation Committee of the Board of Directors of the Issuer determined that the performance\ncriteria was met, resulting in the vesting of the option as to 88,991 shares as of such vesting date."}],"balance_after":88991,"derivative":{"exercise_price":10.83,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":88991},"source":{"system":"sec-edgar","filing":"0000899243-21-049395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924321049395/doc4.xml","form_type":"4"}},{"id":2575938,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option","published_at":"2021-09-08T18:59:16.000Z","date":"2021-09-03","kind":"grant","acquired":true,"shares":169849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable in full on September 3, 2025, with 25% vesting on September 3, 2022, and the remainder vesting in equal monthly installments on the 3rd of each month for the remaining 36 months, subject to the continuous service of the Reporting Person on such vesting date."}],"balance_after":169849,"derivative":{"exercise_price":7.73,"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":169849},"source":{"system":"sec-edgar","filing":"0001192482-21-000710","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000119248221000710/edgar.xml","form_type":"4"}},{"id":3663221,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-12T16:31:11.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":8500,"derivative":{"underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0000899243-19-003299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924319003299/doc4.xml","form_type":"4"}},{"id":3663220,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-12T16:31:11.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly installments from January 1, 2019, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":24900,"derivative":{"exercise_price":40.11,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0000899243-19-003299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924319003299/doc4.xml","form_type":"4"}},{"id":3699104,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-09T21:32:25.000Z","date":"2019-01-07","kind":"tax_withholding","acquired":false,"shares":517,"price":44.2552,"value":22879.9384,"ownership":{"direct":true},"balance_after":1110,"source":{"system":"sec-edgar","filing":"0000899243-19-000911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924319000911/doc4.xml","form_type":"4"}},{"id":3709187,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-03T21:57:35.000Z","date":"2019-01-01","kind":"exercise","acquired":false,"shares":1325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":3975,"derivative":{"underlying":"Common Stock","underlying_shares":1325},"source":{"system":"sec-edgar","filing":"0000899243-19-000408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924319000408/doc4.xml","form_type":"4"}},{"id":3709186,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-03T21:57:35.000Z","date":"2019-01-01","kind":"exercise","acquired":true,"shares":1325,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1627,"source":{"system":"sec-edgar","filing":"0000899243-19-000408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924319000408/doc4.xml","form_type":"4"}},{"id":3723418,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-20T21:23:54.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":302,"price":42.16,"value":12732.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":302,"source":{"system":"sec-edgar","filing":"0000899243-18-031518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318031518/doc4.xml","form_type":"4"}},{"id":3823488,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-06T17:00:21.000Z","date":"2018-09-05","kind":"exercise","acquired":false,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested and became exercisable on December 1, 2017 and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":130000,"derivative":{"exercise_price":15.95,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0000899243-18-023935","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318023935/doc4.xml","form_type":"4"}},{"id":3823487,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-06T17:00:21.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":41400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested and became exercisable on December 1, 2017 and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":133600,"derivative":{"exercise_price":15.95,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":41400},"source":{"system":"sec-edgar","filing":"0000899243-18-023935","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318023935/doc4.xml","form_type":"4"}},{"id":3823486,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-06T17:00:21.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":3600,"price":60,"value":216000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-023935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318023935/doc4.xml","form_type":"4"}},{"id":3823485,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-06T17:00:21.000Z","date":"2018-09-05","kind":"exercise","acquired":true,"shares":3600,"price":15.95,"value":57420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":3600,"source":{"system":"sec-edgar","filing":"0000899243-18-023935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318023935/doc4.xml","form_type":"4"}},{"id":3823484,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-06T17:00:21.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":41400,"price":59.4929,"value":2463006.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-023935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318023935/doc4.xml","form_type":"4"}},{"id":3823483,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-06T17:00:21.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":41400,"price":15.95,"value":660330.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":41400,"source":{"system":"sec-edgar","filing":"0000899243-18-023935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318023935/doc4.xml","form_type":"4"}},{"id":3880530,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-29T17:45:19.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 1, 2016, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option."}],"balance_after":6250,"derivative":{"exercise_price":15.95,"exercise_date":"2018-06-28","expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000899243-18-018747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318018747/doc4.xml","form_type":"4"}},{"id":4096382,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-01-18T19:51:07.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":5300,"derivative":{"underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0000899243-18-001373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318001373/doc4.xml","form_type":"4"}},{"id":4096381,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T19:51:07.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":31800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly  installments from January 1, 2018, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":31800,"derivative":{"exercise_price":52,"expiration_date":"2028-01-15","underlying":"Common Stock","underlying_shares":31800},"source":{"system":"sec-edgar","filing":"0000899243-18-001373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924318001373/doc4.xml","form_type":"4"}},{"id":4533520,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":84720,"kind":"person","name":"Semigran Marc","position":1,"cik":"0001691494","reported_name":"Semigran Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-05T15:58:33.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on December 1, 2017, and the remaining shares subject to this option shall vest and become exercisable in 36 equal monthly installments thereafter.  This option is subject to full acceleration of vesting with respect to all then-unvested shares in the event the reporting person's service relationship is terminated by the issuer or any successor without Cause (as defined in the issuer's 2015 Stock Option and Incentive Plan) within one year following the  consummation of a Sale Event (as defined in the issuer's 2015 Stock Option and Incentive Plan)."}],"balance_after":175000,"derivative":{"exercise_price":15.95,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-16-034906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691494/000089924316034906/doc4.xml","form_type":"4"}}]}